Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
29
HHS Quote, Financials, Valuation and Earnings
Last price:
$4.57
Seasonality move
:
0.07%
Day range:
$4.24 - $4.60
52-week range:
$4.24 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
1.56x
Volume:
3.7K
Avg. volume:
16.7K
1-year change:
-38.43%
Market cap:
$33.5M
Revenue:
$185.2M
EPS (TTM):
-$4.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $176.9M | $194.6M | $206.3M | $191.5M | $185.2M | |
| Revenue Growth (YoY) | -18.7% | 10% | 6% | -7.17% | -3.26% | |
| Cost of Revenues | $49.3M | $50.3M | $61.9M | $59.6M | $56.6M | |
| Gross Profit | $127.6M | $144.3M | $144.3M | $131.9M | $128.6M | |
| Gross Profit Margin | 72.14% | 74.17% | 69.98% | 68.89% | 69.42% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $125.2M | $127.8M | $126.5M | $118.6M | $116.6M | |
| Other Inc / (Exp) | -$15.9M | $3.2M | $4.6M | -$11.1M | -$45.4M | |
| Operating Expenses | $128.8M | $130.3M | $129.2M | $122.9M | $120.9M | |
| Operating Income | -$1.2M | $14M | $15.1M | $9M | $7.7M | |
| Net Interest Expenses | $1.2M | $903K | $438K | -- | $187K | |
| EBT. Incl. Unusual Items | -$18.3M | $16.3M | $19.3M | -$1.9M | -$37.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$16.6M | $1.3M | -$17.5M | -$349K | -$7.6M | |
| Net Income to Company | -$1.7M | $15M | $36.8M | -$1.6M | -$30.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.7M | $15M | $36.8M | -$1.6M | -$30.3M | |
| Basic EPS (Cont. Ops) | -$0.34 | $1.85 | $4.98 | -$0.21 | -$4.15 | |
| Diluted EPS (Cont. Ops) | -$0.34 | $1.76 | $4.75 | -$0.21 | -$4.15 | |
| Weighted Average Basic Share | $6.5M | $6.8M | $7.1M | $7.3M | $7.3M | |
| Weighted Average Diluted Share | $6.5M | $7.2M | $7.5M | $7.3M | $7.3M | |
| EBITDA | -$13.5M | $19.7M | $17.8M | $13.3M | $12M | |
| EBIT | -$17.1M | $17.2M | $15.1M | $9M | $7.7M | |
| Revenue (Reported) | $176.9M | $194.6M | $206.3M | $191.5M | $185.2M | |
| Operating Income (Reported) | -$1.2M | $14M | $15.1M | $9M | $7.7M | |
| Operating Income (Adjusted) | -$17.1M | $17.2M | $15.1M | $9M | $7.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $43.8M | $49.1M | $47.1M | $45.4M | $41.6M | |
| Revenue Growth (YoY) | 7.98% | 12.13% | -3.96% | -3.55% | -8.55% | |
| Cost of Revenues | $11.3M | $12.7M | $14.5M | $13.8M | $14.1M | |
| Gross Profit | $32.5M | $36.3M | $32.7M | $31.7M | $27.5M | |
| Gross Profit Margin | 74.25% | 74.08% | 69.33% | 69.75% | 66.18% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $30.5M | $31.9M | $30.5M | $29.4M | $25.6M | |
| Other Inc / (Exp) | -$2.2M | $39K | -$2.6M | -$1.5M | -$1.4M | |
| Operating Expenses | $31.2M | $32.5M | $31.6M | $30.5M | $26.7M | |
| Operating Income | $1.3M | $3.9M | $1.1M | $1.2M | $798K | |
| Net Interest Expenses | $268K | $134K | -- | $11K | $53K | |
| EBT. Incl. Unusual Items | -$1.2M | $3.8M | -$1.3M | -$242K | -$607K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $591K | $454K | -$532K | -$71K | -$215K | |
| Net Income to Company | -$1.8M | $3.3M | -$791K | -$171K | -$392K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.8M | $3.3M | -$791K | -$171K | -$392K | |
| Basic EPS (Cont. Ops) | -$0.28 | $0.40 | -$0.11 | -$0.02 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.28 | $0.39 | -$0.11 | -$0.02 | -$0.05 | |
| Weighted Average Basic Share | $6.7M | $7M | $7.4M | $7.2M | $7.4M | |
| Weighted Average Diluted Share | $6.7M | $7.3M | $7.4M | $7.2M | $7.4M | |
| EBITDA | -$201K | $4.5M | $2.1M | $815K | $509K | |
| EBIT | -$899K | $3.9M | $1.1M | -$231K | -$554K | |
| Revenue (Reported) | $43.8M | $49.1M | $47.1M | $45.4M | $41.6M | |
| Operating Income (Reported) | $1.3M | $3.9M | $1.1M | $1.2M | $798K | |
| Operating Income (Adjusted) | -$899K | $3.9M | $1.1M | -$231K | -$554K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $180.1M | $199.9M | $204.3M | $189.8M | $181.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $47.3M | $51.7M | $63.7M | $58.9M | $57M | |
| Gross Profit | $132.8M | $148.2M | $140.7M | $131M | $124.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $125.8M | $129.2M | $125.2M | $117.5M | $112.8M | |
| Other Inc / (Exp) | -$16M | $5.4M | $2M | -$10M | -$45.3M | |
| Operating Expenses | $129M | $131.6M | $128.4M | $121.7M | $117.2M | |
| Operating Income | $3.9M | $16.6M | $12.3M | $9.2M | $7.2M | |
| Net Interest Expenses | $1.1M | $769K | $94K | $86K | $229K | |
| EBT. Incl. Unusual Items | -$13.3M | $21.2M | $14.2M | -$838K | -$38.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$4.7M | $1.2M | -$18.4M | $112K | -$7.8M | |
| Net Income to Company | -$8.6M | $20.1M | $32.6M | -$950K | -$30.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$8.6M | $20.1M | $32.6M | -$950K | -$30.5M | |
| Basic EPS (Cont. Ops) | -$1.42 | $2.50 | $4.47 | -$0.12 | -$4.20 | |
| Diluted EPS (Cont. Ops) | -$1.43 | $2.38 | $4.26 | -$0.13 | -$4.20 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$9M | $24.4M | $15.4M | $12M | $10.3M | |
| EBIT | -$12.2M | $22M | $12.2M | $7.8M | $5.9M | |
| Revenue (Reported) | $180.1M | $199.9M | $204.3M | $189.8M | $181.4M | |
| Operating Income (Reported) | $3.9M | $16.6M | $12.3M | $9.2M | $7.2M | |
| Operating Income (Adjusted) | -$12.2M | $22M | $12.2M | $7.8M | $5.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $43.8M | $49.1M | $47.1M | $45.4M | $41.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $11.3M | $12.7M | $14.5M | $13.8M | $14.1M | |
| Gross Profit | $32.5M | $36.3M | $32.7M | $31.7M | $27.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $30.5M | $31.9M | $30.5M | $29.4M | $25.6M | |
| Other Inc / (Exp) | -$2.2M | $39K | -$2.6M | -$1.5M | -$1.4M | |
| Operating Expenses | $31.2M | $32.5M | $31.6M | $30.5M | $26.7M | |
| Operating Income | $1.3M | $3.9M | $1.1M | $1.2M | $798K | |
| Net Interest Expenses | $268K | $134K | -- | $11K | $53K | |
| EBT. Incl. Unusual Items | -$1.2M | $3.8M | -$1.3M | -$242K | -$607K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $591K | $454K | -$532K | -$71K | -$215K | |
| Net Income to Company | -$1.8M | $3.3M | -$791K | -$171K | -$392K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.8M | $3.3M | -$791K | -$171K | -$392K | |
| Basic EPS (Cont. Ops) | -$0.28 | $0.40 | -$0.11 | -$0.02 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.28 | $0.39 | -$0.11 | -$0.02 | -$0.05 | |
| Weighted Average Basic Share | $6.7M | $7M | $7.4M | $7.2M | $7.4M | |
| Weighted Average Diluted Share | $6.7M | $7.3M | $7.4M | $7.2M | $7.4M | |
| EBITDA | -$201K | $4.5M | $2.1M | $815K | $509K | |
| EBIT | -$899K | $3.9M | $1.1M | -$231K | -$554K | |
| Revenue (Reported) | $43.8M | $49.1M | $47.1M | $45.4M | $41.6M | |
| Operating Income (Reported) | $1.3M | $3.9M | $1.1M | $1.2M | $798K | |
| Operating Income (Adjusted) | -$899K | $3.9M | $1.1M | -$231K | -$554K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $29.4M | $11.9M | $10.4M | $18.4M | $9.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $36M | $41.1M | $39.7M | $34.3M | $31.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $9.6M | $1.9M | $2.2M | $1.9M | $1.5M | |
| Other Current Assets | $886K | $1M | $1.6M | $928K | $1.4M | |
| Total Current Assets | $86.2M | $75.4M | $66.3M | $65.2M | $53.6M | |
| Property Plant And Equipment | $30.6M | $29.9M | $29.7M | $34.3M | $31.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $2.4M | $1.9M | $295K | |
| Other Intangibles | -- | -- | $3.5M | $2.8M | $563K | |
| Other Long-Term Assets | $2.6M | $2.6M | $1.7M | $1.3M | $717K | |
| Total Assets | $119.5M | $107.9M | $120M | $122.8M | $101.8M | |
| Accounts Payable | $16.3M | $16.1M | $22.5M | $23.2M | $21.8M | |
| Accrued Expenses | $5.2M | $7M | $6.7M | $5.6M | $3.2M | |
| Current Portion Of Long-Term Debt | $4.9M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.7M | $6.6M | $5.7M | $4.8M | $3.7M | |
| Other Current Liabilities | $2.9M | $2.3M | $2.9M | $9.5M | $3.1M | |
| Total Current Liabilities | $47.2M | $42.4M | $43.6M | $48.1M | $35.1M | |
| Long-Term Debt | $22.2M | $5M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $162.9M | $122.9M | $101.2M | $102.9M | $80.1M | |
| Common Stock | $21.8M | $21.8M | $12.2M | $12.2M | $12.2M | |
| Other Common Equity Adj | -$65.6M | -$53.3M | -$48.3M | -$44.1M | -$13.6M | |
| Common Equity | -$53.1M | -$24.7M | $18.8M | $19.9M | $21.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$43.4M | -$15M | $18.8M | $19.9M | $21.7M | |
| Total Liabilities and Equity | $119.5M | $107.9M | $120M | $122.8M | $101.8M | |
| Cash and Short Terms | $29.4M | $11.9M | $10.4M | $18.4M | $9.9M | |
| Total Debt | $27.1M | $5M | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.9M | $9.7M | $13.1M | $11.5M | $9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $45.4M | $49M | $37.2M | $32.8M | $29.6M | |
| Inventory | $42K | -- | -- | -- | -- | |
| Prepaid Expenses | $10.8M | $9.4M | $3.4M | $2.2M | $2.1M | |
| Other Current Assets | $814K | $1.2M | $1.2M | $1.3M | $1.3M | |
| Total Current Assets | $83.9M | $79.9M | $62.2M | $57.8M | $53.7M | |
| Property Plant And Equipment | $30.1M | $28.9M | $29.3M | $32.9M | $30.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $2.4M | $1.9M | $295K | |
| Other Intangibles | -- | -- | $3.4M | $2.6M | $514K | |
| Other Long-Term Assets | $2.8M | $2.4M | $1.6M | $1.1M | $656K | |
| Total Assets | $116.9M | $111.1M | $114.9M | $113.4M | $100.6M | |
| Accounts Payable | $16.1M | $19.6M | $20M | $16M | $22M | |
| Accrued Expenses | $6.8M | $4.3M | $3.4M | $4.7M | $3.6M | |
| Current Portion Of Long-Term Debt | $8.7M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $7.1M | $5.8M | $5.9M | $4.5M | $3.9M | |
| Other Current Liabilities | $2.9M | $2.9M | $2.9M | $9.6M | $2.5M | |
| Total Current Liabilities | $53.1M | $44.6M | $38.3M | $40.2M | $36.1M | |
| Long-Term Debt | $18.4M | $5M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $161.6M | $122M | $93.9M | $93.5M | $79.2M | |
| Common Stock | $21.8M | $21.8M | $12.2M | $12.2M | $12.2M | |
| Other Common Equity Adj | -$65.3M | -$52.8M | -$45.7M | -$44.3M | -$13.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$44.7M | -$10.8M | $21M | $20M | $21.4M | |
| Total Liabilities and Equity | $116.9M | $111.1M | $114.9M | $113.4M | $100.6M | |
| Cash and Short Terms | $24.9M | $9.7M | $13.1M | $11.5M | $9M | |
| Total Debt | $27.1M | $5M | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.7M | $15M | $36.8M | -$1.6M | -$30.3M | |
| Depreciation & Amoritzation | $3.6M | $2.6M | $2.7M | $4.2M | $4.4M | |
| Stock-Based Compensation | $764K | $1.5M | $2.4M | $1.4M | $1.9M | |
| Change in Accounts Receivable | -$931K | -$9.2M | $3.8M | $5.7M | $2.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$7.8M | -$1.8M | $28.8M | $10.5M | -$3M | |
| Capital Expenditures | $2.7M | $3M | $5.8M | $2.8M | $3.7M | |
| Cash Acquisitions | -- | -- | -$5.8M | $500K | -- | |
| Cash From Investing | -$775K | -$2.9M | -$11.5M | -$2.3M | -$3.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10M | $5M | -- | -- | -- | |
| Long-Term Debt Repaid | -$2M | -$17.3M | -$5.2M | -$160K | -$124K | |
| Repurchase of Common Stock | -$22K | -- | -$10.5M | -$3M | -$295K | |
| Other Financing Activities | -$653K | -$795K | -$131K | -$45K | -- | |
| Cash From Financing | $7.3M | -$13.4M | -$15.8M | -$3.2M | -$419K | |
| Beginning Cash (CF) | $34.1M | $33.6M | $15.1M | $11.4M | $18.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.3M | -$18.1M | $1.5M | $5M | -$7.2M | |
| Ending Cash (CF) | $33.6M | $15.1M | $11.4M | $18.9M | $9.9M | |
| Levered Free Cash Flow | -$10.5M | -$4.8M | $23M | $7.7M | -$6.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.8M | $3.3M | -$791K | -$171K | -$392K | |
| Depreciation & Amoritzation | $698K | $599K | $1.1M | $1M | $1.1M | |
| Stock-Based Compensation | $222K | $288K | $540K | $552K | -$49K | |
| Change in Accounts Receivable | -$3.6M | -$7.2M | $3.5M | $1.2M | -$497K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.7M | -$764K | $1.7M | -$5.7M | -$818K | |
| Capital Expenditures | $735K | $1.4M | $566K | $526K | $105K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$735K | -$1.4M | -$565K | -$525K | -$103K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$56K | -$55K | -$47K | -$17K | -$40K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$113K | -$93K | -$6K | -$45K | -- | |
| Cash From Financing | -$199K | -$282K | -$265K | -$149K | -$68K | |
| Beginning Cash (CF) | $33.6M | $15.1M | $11.4M | $18.9M | $9.9M | |
| Foreign Exchange Rate Adjustment | -$458K | -$504K | $1.9M | -$534K | $37K | |
| Additions / Reductions | -$6.6M | -$2.4M | $874K | -$6.4M | -$989K | |
| Ending Cash (CF) | $26.5M | $12.2M | $14.1M | $12M | $9M | |
| Levered Free Cash Flow | -$6.4M | -$2.2M | $1.1M | -$6.2M | -$923K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$8.6M | $20.1M | $32.6M | -$950K | -$30.5M | |
| Depreciation & Amoritzation | $3.2M | $2.5M | $3.2M | $4.2M | $4.4M | |
| Stock-Based Compensation | $771K | $1.5M | $2.6M | $1.4M | $1.3M | |
| Change in Accounts Receivable | -$7.6M | -$12.8M | $14.5M | $3.4M | $696K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$9.5M | $3.1M | $31.3M | $3.1M | $1.9M | |
| Capital Expenditures | $2.6M | $3.7M | $4.9M | $2.8M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$874K | -$3.5M | -$10.7M | -$2.3M | -$3.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2M | -$17.3M | -$5.2M | -$130K | -$147K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$637K | -$775K | -$44K | -$84K | -- | |
| Cash From Financing | $7.4M | -$13.5M | -$15.8M | -$3.1M | -$338K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.1M | -$13.9M | $4.8M | -$2.3M | -$1.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$12.1M | -$592K | $26.3M | $309K | -$1.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.8M | $3.3M | -$791K | -$171K | -$392K | |
| Depreciation & Amoritzation | $698K | $599K | $1.1M | $1M | $1.1M | |
| Stock-Based Compensation | $222K | $288K | $540K | $552K | -$49K | |
| Change in Accounts Receivable | -$3.6M | -$7.2M | $3.5M | $1.2M | -$497K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.7M | -$764K | $1.7M | -$5.7M | -$818K | |
| Capital Expenditures | $735K | $1.4M | $566K | $526K | $105K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$735K | -$1.4M | -$565K | -$525K | -$103K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$56K | -$55K | -$47K | -$17K | -$40K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$113K | -$93K | -$6K | -$45K | -- | |
| Cash From Financing | -$199K | -$282K | -$265K | -$149K | -$68K | |
| Beginning Cash (CF) | $33.6M | $15.1M | $11.4M | $18.9M | $9.9M | |
| Foreign Exchange Rate Adjustment | -$458K | -$504K | $1.9M | -$534K | $37K | |
| Additions / Reductions | -$6.6M | -$2.4M | $874K | -$6.4M | -$989K | |
| Ending Cash (CF) | $26.5M | $12.2M | $14.1M | $12M | $9M | |
| Levered Free Cash Flow | -$6.4M | -$2.2M | $1.1M | -$6.2M | -$923K | |
Get HHS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HHS
Sector
P/E ratio
--
17.05x
PEG ratio
0.00x
0.00x
P/B ratio
1.56x
1.44x
Price / LTM sales
0.18x
0.95x
Growth Metrics
HHS
Sector
Revenue growth
-8.55%
-0.19%
Earnings growth
-75%
-1.02%
Revenue (5-year growth)
-3.17%
1.59%
Earnings forecast
--
$0.04
Profitability
HHS
Sector
Profitability FY 2024
$128.6M
$269.7M
Return on invested capital
-145.7%
0.22%
Return on assets
-28.59%
-0.05%
Return on equity
-145.7%
1.9%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
13
Balance Sheet
HHS
Sector
Total cash
$9M
$104.5M
Short term investments
--
$28.1M
Total assets
$101.8M
$851.1M
Long term debt
--
$42.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
